Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut 
Microbiota Alterations.

Moschen, Alexander R; Gerner, Romana R; Wang, Jun; Klepsch, Victoria; Adolph, Timon E; Reider, Simon J; Hackl, Hubert; Pfister, Alexandra; Schilling, Johannes; Moser, Patrizia L; Kempster, Sarah L; Swidsinski, Alexander; Orth Höller, Dorothea; Weiss, Gunter; Baines, John F.; Kaser, Arthur; Tilg, Herbert

doi:10.1016/j.chom.2016.03.007

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations.

MPS-Authors

/persons/resource/persons82474

Wang, Jun
Guest Group Evolutionary Genomics, Max Planck Institute for Evolutionary Biology, Max Planck Society;

/persons/resource/persons56580

Baines, John F.
Guest Group Evolutionary Genomics, Max Planck Institute for Evolutionary Biology, Max Planck Society;

External Resource

http://www.sciencedirect.com/science/article/pii/S1931312816300993
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Moschen&Gerner_CH&M.R1_main document_final.pdf
(Postprint), 302KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., et al. (2016). Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations. Cell Host & Microbe, 19(4), 455-469. doi:10.1016/j.chom.2016.03.007.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-088B-3

Abstract

High mucosal and fecal concentrations of the antimicrobial siderophore-binding peptide Lipocalin-2 (Lcn2) are observed in inflammatory bowel disease. However, Lcn2 function in chronic intestinal inflammation remains unclear. Here, we demonstrate that Lcn2 protects from early-onset colitis and spontaneous emergence of right-sided colonic tumors resulting from IL-10 deficiency. Exacerbated inflammation in Lcn2(-/-)/Il10(-/-) mice is driven by IL-6, which also controls tumorigenesis. Lcn2(-/-)/Il10(-/-) mice exhibit profound alterations in gut microbial composition, which contributes to inflammation and tumorigenesis, as demonstrated by the transmissibility of the phenotype and protection conferred by antibiotics. Specifically, facultative pathogenic Alistipes spp. utilize enterobactin as iron source, bloom in Lcn2(-/-)/Il10(-/-) mice, and are sufficient to induce colitis and right-sided tumors when transferred into Il10(-/-) mice. Our results demonstrate that Lcn2 protects against intestinal inflammation and tumorigenesis associated with alterations in the microbiota.